Prophylactic lithium

August 1970
British Medical Journal;8/29/1970, Vol. 3 Issue 5721, p479
Academic Journal
No abstract available.


Related Articles

  • AKT answer relating to management of bipolar affective disorder.  // InnovAiT;May2011, Vol. 4 Issue 5, p314 

    The article offers information on the effectiveness of the combination of prophylactic agents including lithium, olanzapine and sodium valproate as a treatment for bipolar disorder.

  • Is lithium still the gold standard in the treatment of bipolar disorders? Moller, Hans-Jurgen // European Archives of Psychiatry & Clinical Neuroscience;2003, Vol. 253 Issue 3, p113 

    Examines the efficacy of lithium in the prophylactic treatment of bipolar disorders and the acute treatment of mania. Reason that clinicians have the impression that lithium does not always appear to be as effective as previously; Focus of the criticism about the impact of lithium in the...

  • Lithium in bipolar mood disorder. Dinan, Timothy G. // BMJ: British Medical Journal (International Edition);4/27/2002, Vol. 324 Issue 7344, p989 

    Editorial. Discusses the use of lithium to treat bipolar affective disorder, also known as manic depression. Decline in the prescribing of lithium in the U.S.; Evidence that lithium should be the first choice in the prophylactic treatment of bipolar disorder; Side effects of lithium, including...

  • How long is it safe to stay on lithium? Mackin, Paul // Pulse;5/10/2004, Vol. 64 Issue 19, p84 

    Discusses time limit to the use of lithium as a prophylactic agent for mood disorders. Risk for cognitive impairment; Lithium withdrawal symptoms; Side-effects; Basis for discontinuation of treatment.

  • Lithium in the prophylaxis of unipolar depression: a review. Coppen, Alec; Abou-Saleh, M. T. // Journal of the Royal Society of Medicine;Apr1983, Vol. 76 Issue 4, p297 

    The article discusses the use of lithium prophylaxis for the treatment of unipolar depression. Unipolar depressive illness is an episodic recurrent disease with a very high continuing morbidity. A study reported that at least 40 percent of unipolar patients would require prophylactic treatment....

  • Pharmacological and Clinical Problems of Lithium Prophyl axis. Schou, M.; Baastrup, P. C.; Grof, P.; Weis, P.; Angst, J. // British Journal of Psychiatry;Jun70, Vol. 116 Issue 535, p615 

    The article presents a study on the pharmacological and clinical problems of lithium prophylaxis. The study revealed lithium as an active prophylactic agent in recurrent affective disorders, and its systematic use can lead to improvement of the disease course in most patients. Lithium treatment...

  • Prophylactic lithium: a double-blind trial in recurrent affective disorders. Melia, P. I. // British Journal of Psychiatry;Jun70, Vol. 116 Issue 535, p621 

    The article discusses the results of a study, in which a double-blind trial of prophylactic lithium in recurrent affective disorders was performed. The study investigated the hypothesis that lithium reduces the frequency of manic and depressive episodes in patients with hitherto frequently...

  • Prophylactic lithium in puerperal psychosis. The experience of three centres. Stewart, D. E.; Klompenhouwer, J. L.; Kendell, R. E.; Van Hulst, A. M. // British Journal of Psychiatry;Mar91, Vol. 158, p393 

    At three centres, 21 women at high risk for puerperal psychosis were given prophylactic lithium carbonate late in the third trimester of pregnancy or immediately after delivery. Only two of the women had a recurrence of their psychotic illness while on prophylactic lithium. One woman given...

  • Serotonin transporter gene associated with lithium prophylaxis in mood disorders. Serretti, A.; Lili, R.; Mandelli, L.; Lorenzi, C.; Smeraldi, E. // Pharmacogenomics Journal;2001, Vol. 1 Issue 1, p71 

    Presents a study that investigated the possible association between the functional polymorphism in the upstream regulatory region of the serotonin transporter gene and the prophylactic efficacy of lithium in mood disorders. Method of the study; Results and discussion; Conclusion.

  • Lithium treatment: a refresher course. Schou, M. // British Journal of Psychiatry;Nov86, Vol. 149, p541 

    Updated guidelines are presented for the safe and effective use of lithium; covering indications, treatment management, duration of prophylactic treatment, side-effects and their prevention, overdosage, interactions, and contraindications. Alternatives to lithium and patient-doctor co-operation...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics